Protalix BioTherapeutics
Protalix BioTherapeutics, a pioneering biopharmaceutical company headquartered in Israel, focuses on developing and commercialising innovative therapies for rare diseases. Founded in 2003, Protalix has made significant strides in the biotechnology sector, particularly in the production of therapeutic proteins using its proprietary plant cell-based expression system.
The company’s flagship product, Elelyso, is a unique enzyme replacement therapy for Gaucher disease, showcasing Protalix's commitment to addressing unmet medical needs. With a strong emphasis on research and development, Protalix BioTherapeutics has positioned itself as a leader in the biopharmaceutical industry, achieving notable milestones in regulatory approvals and partnerships. Its operational reach extends beyond Israel, impacting patients globally with its cutting-edge therapies.
-20 vs industry average
Protalix BioTherapeutics’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Protalix BioTherapeutics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Protalix BioTherapeutics yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Protalix BioTherapeutics’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Protalix BioTherapeutics yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Protalix BioTherapeutics
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project